WArts Randomised Treatment Study 2.
- Conditions
- Patients with hand- or plantar warts of the type vulgaris.
- Registration Number
- NL-OMON25205
- Lead Sponsor
- Prof. dr.WJJ Assendelft, head of department Public Health and Primary CareLeiden University Medical Centre
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 400
Inclusion Criteria
All patients from the age of 4 onward, who present themselves to their general practitioner with one or more new warts of the type vulgaris on commons or feet.
Exclusion Criteria
Immunocompromised patients, patients with mosaic warts larger than 1 cm in diameter, women who are pregnant or who are breastfeeding their children.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ‘Cure', meaning all common- and plantar wart(s) have totally disappeared (normal skin) at 13 weeks.
- Secondary Outcome Measures
Name Time Method The number of warts that still exist at follow-up, the subjective hindrance caused by the warts as well as by the treatment, pain and other adverse effects of the treatment, subjective judgement of the effect of the treatment by the patient, objective judgement of the effect of the treatment by the research nurse at follow up, the consumption of co-interventions during follow-up.